FDA updates recalled valsartan-containing products, click here for more information

The FDA continues to evaluate valsartan-containing products and has updated the list of products included in the recall and the list of products not included in the recall. In addition to updating the lists, the agency will continue to provide information when it becomes available.

The FDA is working with drug manufacturers to ensure future valsartan active pharmaceutical ingredients (APIs) are not at risk of NDMA formation. If you were prescribed Valsartan or a valsartan-containing product please review the list and contact us for an alternative prescription.